Correcting impotence in the male dialysis patient: Experience with testosterone replacement and vacuum tumescence therapy

American Journal of Kidney Diseases

Volumn 31, Issue 2, 1998, Pages 313-319

  Lawrence, Ian G ^a   Price, David E ^b   Howlett, Trevor A ^b   Harris, Kevin P G ^b   Feehally, John ^b   Walls, John ^b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

End stage renal failure (ESRF); Impotence; Sexual dysfunction; Testosterone; Vacuum tumescence therapy

Indexed keywords

TESTOSTERONE ENANTATE;

ADULT; ANDROGEN THERAPY; ARTICLE; DEVICE; DIALYSIS; FLUID RETENTION; HUMAN; HYPOGONADISM; IMPOTENCE; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; TREATMENT OUTCOME;

EID: 0031908328     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9469503     Document Type: Article

References (38)

1. Procci WR, Goldstein DA, Adelstein J, Massry SG: Sexual dysfunction in the male patient with uremia: A reappraisal. Kidney Int 19:317-323, 1981
2. Rodger RS, Fletcher K, Dewar JH, Genner D, McHugh M, Wilkinson R, Ward MK, Kerr DNS: Prevalence and pathogenesis of impotence in one hundred uremic men. Uremia Invest 8:89-96, 1984-85
3. Lawrence IG, Howlett TA: Endocrine manifestations of systemic disease: The kidney, in Grossman AB (ed): Clinical Endocrinology (ed 2), chap 78. Cambridge, MA, Blackwell Science, 1998, pp 1067-1076
4. Uttley L: Assessment and treatment of sexual dysfunction in chronic renal failure. Dial Transplant 25:19-25, 35, 1996
5. Evans RW, Rader B, Manninen DL, and the Cooperative Multicenter EPO Clinical Trial Group: The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263:825-830, 1990
6. Bommer J, Kugel M, Schwöbel B, Ritz E, Barth HP, Seelig R: Improved sexual function during recombinant human erythropoietin therapy. Nephrol Dial Transplant 5:204-207, 1990
7. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 300:573-578, 1990
8. Lawrence IG, Price DE, Howlett TA, Harris KPG, Feehally J, Walls J: Erythropoietin and sexual dysfunction. Nephrol Dial Transplant 12:741-747, 1997
9. Bommer J, Ritz E, Del Pozo E, Bommer G: Improved sexual function in male haemodialysis patients on bromocriptine. Lancet 2:496-497, 1979
10. Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD: Effect of oral zinc therapy on gonadal function in hemodialysis patients: A double blind study. Ann Intern Med 97:357-361, 1982
11. Lim VS, Fang VS: Restoration of plasma testosterone levels in uremic men with clomiphene citrate. J Clin Endocrinol Metab 43:1370-1377, 1976
12. Muir JW, Besser GM, Edwards CRW, Rees LH, Cattell WR, Ackrill P, Baker LRI: Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis. Clin Nephrol 20:308-314, 1983
13. Brook AC, Johnston DG, Ward MK, Watson MJ, Cook DB, Kerr DNS: Absence of a therapeutic effect of zinc in the sexual dysfunction of haemodialysed patients. Lancet 2:618-620, 1980
14. Martin-Malo A, Benito P, Castillo D, Espinosa M, Burdiel LG, Perez R, Aljama P: Effect of clomiphene citrate on hormonal profile in male hemodialysis and kidney transplant patients. Nephron 63:390-394, 1993
15. Wiles PG: Successful non-invasive management of erectile impotence in diabetic men. Br Med J 296:161-162, 1988
16. Kolettis PN, Lakin MM, Montague DK, Ingleright BJ, Ausmundson S: Efficacy of the vacuum constriction device in patients with corporeal venous occlusive dysfunction. Urology 46:856-858, 1995
17. Linet OI, Ogrine FG: Efficacy and safety of intracavernosal Alprostadil in men with erectile dysfunction. N Engl J Med 334:873-877, 1996
18. Randrup E, Suarez G, Wilson S, Mekras G, Mobley D, Baum N: Clinical experience with Mentor Alpha I inflatable penile prosthesis. Urology 42:305-308, 1993
19. Kearse WS, Sago AL, Peretsman SJ, Bolton JO, Holcomb RG, Reddy PK, Bernhard PH, Eppel SM, Lewis JH, Gladshteyn M, Melman AA: Report of a multicenter clinical evaluation of the Dura-II penile prosthesis. J Urol 155:1613-1616, 1996
20. Davidson JM, Camargo CA, Smith ER: Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 48:955-958, 1979
21. Bals-Pratsch M, Knuth UA, Yoon Y-D, Nieschlag E: Transdermal testosterone substitution therapy for male hypogonadism. Lancet 2:943-946, 1986
22. Arver S, Dobs AS, Meikle AW, Allen RP, Sanders SW, Mazer NA: Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system. J Urol 155:1604-1608, 1996
23. Van Coevorden A, Stolear J-C, Dhaene M, Van Herweghem J-L, Mockel J: Effect of chronic testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol 26:48-54, 1986
24. Hendler ED, Goffinet JA, Ross S, Longnecker RE, Bakovic V: Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 291:1046-1051, 1974
25. Cattran DC, Fenton SSA, Wilson DR, Oreopoulos D, Shimizu A, Richardson RM: A controlled trial of nandrolone decanoate in the treatment of uremic anemia. Kidney Int 12:430-437, 1977
26. Cookson MS, Nadig PW: Long-term results with vacuum constriction device. J Urol 149:290-294, 1993
27. Moul JW, McLeod DG: Negative pressure devices in the explanted penile prosthesis population. J Urol 142:729-731, 1989
28. Moul JW: Long-term results with vacuum constriction device: Editorial comment. J Urol 149:294, 1993
29. Wiles PG: Erectile impotence in diabetic men: Aetiology, investigation, and management. Diabetic Med 9:888-892, 1992
30. Price DE, Cooksey G, Jehu D, Bentley S, Hearnshaw JR, Osborn DE: The management of impotence in diabetic men by vacuum tumescence therapy. Diabetic Med 8:964-967, 1991
31. Limoge JP, Olins E, Henderson D, Donatucci CF: Minimally invasive therapies in the treatment of erectile dysfunction in anticoagualated cases: A study of satisfaction and safety. J Urol 155:1277-1279, 1996
32. Lipshultz LI: Injection therapy for erectile dysfunction. N Engl J Med 334:913-914, 1996
33. Gould JE, Switters DM, Broderick GA, deVere White RW: External vacuum devices: A clinical comparison with pharmacologic erections. World J Urol 10:68-70, 1992
34. Greenspan SL, Oppenheim DS, Klibanski A: Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110:526-531, 1989
35. Bagatell CJ, Bremner WJ: Androgens in men: Uses and abuses. N Engl J Med 334:707-714, 1996
36. Soliman G, Oreopoulos DG: Anabolic steroids and malnutrition in chronic renal failure. Perit Dial Int 14:362-365, 1994
37. Dombros NV, Digenis GE, Soliman G, Oreopoulos DG: Anabolic steroids in the treatment of malnourished CAPD patients: A retrospective study. Perit Dial Int 14:344-347, 1994
38. Crook D: Testosterone, androgens and the risk of myocardial infarction. Br J Clin Pract 50:180-181, 1996